Imunon, Inc.·4

Jun 29, 4:22 PM ET

Tardugno Michael H 4

4 · Imunon, Inc. · Filed Jun 29, 2026

Research Summary

AI-generated summary of this filing

Updated

Imunon (IMNN) Exec Chairman Michael Tardugno Receives 42,519 Shares

What Happened
Michael H. Tardugno, Executive Chairman and Director of Imunon, Inc. (IMNN), was granted 42,519 shares on 2026-06-25 at an attributed price of $1.72 per share, for a total value of $73,133. The transaction is coded as an award/grant (A) — an acquisition of stock, not an open-market purchase.

Key Details

  • Transaction date: 2026-06-25; filing date: 2026-06-29 (filed within required Form 4 timeframe).
  • Shares granted: 42,519; price used for reporting: $1.72 per share; total value: $73,133.
  • Footnote: Stock granted in lieu of cash for 50% of the 2025 annual cash bonus.
  • Transaction type: Grant/Award (not a sale or open-market buy).
  • Shares owned after transaction: Not specified in the provided filing details.

Context
This was a compensation-related grant (conversion of bonus into equity), which is common and primarily reflects company pay practices rather than a direct market bet by the insider. Awards like this increase insider ownership but are different from voluntary purchases (which some investors view as stronger bullish signals).

Insider Transaction Report

Form 4
Period: 2026-06-25
Tardugno Michael H
DirectorExecutive Chairman of Board
Transactions
  • Award

    Common Stock

    [F1]
    2026-06-25$1.72/sh+42,519$73,13359,986 total
Holdings
  • Common Stock

    (indirect: By IRA)
    4,622
Footnotes (1)
  • [F1]Stock granted in lieu of cash for 50% of 2025 annual cash bonus
Signature
/s/ Susan Eylward, Attorney-in-Fact for Michael Tardugno|2026-06-29

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4